文献速递类风湿关节炎痛风与晶体性关节病

通过Rx-Risk共病指数使用药物概念对多病共存进行分类:方法与比较性横断面研究

Classifying Multimorbidity Using Drug Concepts via the Rx-Risk Comorbidity Index: Methods and Comparative Cross-Sectional Study.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2024-03-10

该研究更新了仅用药物信息识别共病的方法,将RxCUI、NDC和ATC代码映射至Rx-Risk共病指数,并在类风湿关节炎和骨关节炎队列中比较Rx-Risk与Charlson、RDCI、Elixhauser等传统共病指数的分布差异。结果显示Rx-Risk中位评分远高于传统指数,在Charlson评分为0的患者中Rx-Risk评分范围仍可达0至16以上。

要点

  • Rx-Risk共病指数可仅基于药物信息识别共病,适用于诊断编码可能捕获不足的场景。
  • 类风湿关节炎队列中Rx-Risk中位评分6.00远高于Charlson、RDCI和Elixhauser的中位评分。
  • Charlson评分为0的患者占85%,其Rx-Risk评分范围仍为0至16以上。

核心结论

  • 使用以药物为中心的共病指数可在很大程度上克服单专科电子健康记录中共病的错误分类和漏判。

研究设计与样本

  • 研究利用First Databank、RxNorm及其网络客户端RxNav和RxClass,将RxCUI、NDC和ATC代码映射至Rx-Risk共病指数。
  • 在风湿病学有效性信息学系统注册库中的 established 类风湿关节炎和骨关节炎队列中,比较Rx-Risk与其他共病指数的分布。

主要发现

  • 识别出965个代表46个Rx-Risk共病类别的独特成分RxCUI,排除剂型和成分相关RxCUI后,映射了80,911个独特相关RxCUI至该指数。
  • 获得并映射了187,024个独特NDC和354个ATC代码至指数类别。
  • 类风湿关节炎队列中,Rx-Risk中位评分为6.00(第25百分位2,第75百分位9),远高于Charlson中位评分0(第25百分位0,第75百分位0)、RDCI中位评分0(第25百分位0,第75百分位0)和Elixhauser中位评分1(第25百分位1,第75百分位1)。
  • 骨关节炎队列分析结果类似。
  • Charlson评分为0的患者占总数的85%,其RDCI和Elixhauser评分接近1,而Rx-Risk评分范围为0至16以上。

关键数值与推荐

  • Rx-Risk指数涵盖46个共病类别,映射了965个独特成分RxCUI、80,911个独特相关RxCUI、187,024个独特NDC和354个ATC代码。
  • 类风湿关节炎队列中,Rx-Risk中位评分6.00(第25百分位2,第75百分位9),Charlson中位评分0(第25百分位0,第75百分位0),RDCI中位评分0(第25百分位0,第75百分位0),Elixhauser中位评分1(第25百分位1,第75百分位1)。
  • Charlson评分为0的患者占85%,其RDCI和Elixhauser评分接近1,Rx-Risk评分范围为0至16以上。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The study objective was to update a method to identify comorbid conditions using only medication information in circumstances in which diagnosis codes may be undercaptured, such as in single-specialty electronic health records (EHRs), and to compare the distribution of comorbidities across Rx-Risk versus other traditional comorbidity indices. METHODS: Using First Databank, RxNorm, and its web-based clients, RxNav and RxClass, we mapped Drug Concept Unique Identifiers (RxCUIs), National Drug Codes (NDCs), and Anatomical Therapeutic Chemical (ATC) codes to Rx-Risk, a medication-focused comorbidity index. In established rheumatoid arthritis (RA) and osteoarthritis (OA) cohorts within the Rheumatology Informatics System for Effectiveness registry, we then compared Rx-Risk with other comorbidity indices, including the Charlson Comorbidity Index, Rheumatic Disease Comorbidity Index (RDCI), and Elixhauser. RESULTS: We identified 965 unique ingredient RxCUIs representing the 46 Rx-Risk comorbidity categories. After excluding dosage form and ingredient related RxCUIs, 80,911 unique associated RxCUIs were mapped to the index. Additionally, 187,024 unique NDCs and 354 ATC codes were obtained and mapped to the index categories. When compared to traditional comorbidity indices in the RA cohort, the median score for Rx-Risk (median 6.00 [25th percentile 2, 75th percentile 9]) was much greater than for Charlson (median 0 [25th percentile 0, 75th percentile 0]), RDCI (median 0 [25th percentile 0, 75th percentile 0]), and Elixhauser (median 1 [25th percentile 1, 75th percentile 1]). Analyses of the OA cohort yielded similar results. For patients with a Charlson score of 0 (85% of total), both the RDCI and Elixhauser were close to 1, but the Rx-Risk score ranged from 0 to 16 or more. CONCLUSION: The misclassification and under-ascertainment of comorbidities in single-specialty EHRs can largely be overcome by using a medication-focused comorbidity index.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Vanderbleek JJ, Owensby JK, McAnnally A, et al. Classifying Multimorbidity Using Drug Concepts via the Rx-Risk Comorbidity Index: Methods and Comparative Cross-Sectional Study. Arthritis Care Res (Hoboken). 2024. PMID: 37986017. doi:10.1002/acr.25273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。